URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.
Referred to HLT, CPC, referral sheet 19
Email me when HCR 134 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HCR 134. By continuing you agree to the Terms and Privacy Policy.
Summary
The concurrent resolution asks the Hawaii State Director of Health to issue a statewide order permitting people to buy nebulized budesonide without a prescription or doctor’s consultation. It also encourages the Board of Pharmacy to set labeling and instruction rules for the product and its nebulizer devices. The measure aims to expand access to a medication the sponsors say can help treat respiratory illnesses like COVID‑19.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HCR 134
3 free questions a day, no accountHistory
- Referred to HLT, CPC, referral sheet 19
- Offered
Sponsors
- ALCOS · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HCR 134 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HCR 134 freeOr ask your AI assistant about HCR 134 directly:
Add to Claude, ChatGPT or Cursor